EUVIMEDEUVIMED entdecken
Crossref

Urodynamic Changes Following a Staged Trial of Sacral Neuromodulation in Patients With Detrusor Underactivity

Stewart Whalen iD, Jaraspong Vuthiwong iD, Liang G Qu iD, Johan Gani

Neurourology and Urodynamics · 2025

DOI: 10.1002/nau.70035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurourology and Urodynamics, 2025. Verfasst von Stewart Whalen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Austin Health, Heidelberg, Victoria, Australia. Hauptthemen laut MEDLINE: Urodynamics, Urinary Bladder, Underactive, Electric Stimulation Therapy, Urinary Bladder. Die Arbeit nennt 16 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Sacral neuromodulation (SNM) is an established treatment for detrusor underactivity (DU) and nonobstructive urinary retention. The mechanism of action for SNM in DU, however, remains poorly understood. The objective of this study was to investigate the urodynamic study (UDS) changes in DU patients during the trial period following first stage tined‐lead placement (FSTLP). Materials and Methods Retrospective chart review was performed to identify patients diagnosed with DU on initial UDS, who had repeat UDS during the 2‐week trial period following FSTLP by a single clinician. Urodynamic parameters including maximum flow rate (Qmax), detrusor pressure at maximum flow (PdetQmax), post‐void residual (PVR), voiding efficiency (VE), and detrusor contractility index (DCI) were collected. Using the definition of improvement in baseline VE of ≥ 50% post‐FSTLP or improvement in DCI of ≥ 50% in complete voiders, patients were divided into “responders” and “nonresponders.” Pre‐ and post‐FSTLP urodynamic findings were compared using Wilcoxon signed‐rank tests.

Results

A total of 17 patients were identified who met the inclusion criteria. Repeat UDS were done on account of inability or unwillingness to perform clean intermittent catheterization and thus inability to chart an accurate bladder diary. There were 9 female and 8 male patients. Four patients (23.5%) had pure DU while the other 13 (76.5%) had concurrent detrusor overactivity (DO–DU). Among all patients, there was a statistically significant improvement in PdetQmax (14 vs. 29 cmH 2 O, p < 0.01) and DCI (62 vs. 92, p < 0.01). Six patients (35.3%) responded to the trial of SNM for DU. Among responders, statistically significant improvements in Qmax (5 vs. 15.5 mL/s, p = 0.03), PVR (215 vs. 80 mLs, p = 0.04), VE (22.9% vs. 82.5%, p = 0.04), and DCI (29 vs. 97.5, p = 0.03) were observed. Nonresponders had improvement in PdetQmax (14 vs. 29 cmH 2 O, p = 0.02), but not in Qmax (9 vs. 10 mL/s, p = 0.89).

Conclusions

Among all patients, an improvement in PdetQmax and DCI was observed. Responders exhibited improvement in Qmax, PVR, VE, and DCI without statistically significant improvement in PdetQmax. Nonresponders had statistically significant improvement in PdetQmax, but not in Qmax. Possible mechanisms of action of SNM in DU patients based on our data are inhibition of the guarding reflex/relaxation of the urethra (shown by improvement in Qmax in responders only) and direct strengthening of bladder contractility (shown by improvement in PdetQmax in all patients). Improvement in Qmax was observed exclusively in responders suggesting the former mechanism is the predominant one. Further larger prospective studies are required to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UrodynamicsUrinary Bladder, UnderactiveElectric Stimulation TherapyUrinary BladderLumbosacral PlexusHumansFemaleMaleMiddle AgedRetrospective StudiesTreatment OutcomeAgedAdultSacrum

Stichwörter der Autor:innen

detrusor underactivitysacral neuromodulationurodynamics

Autor:innen und Institutionen

  • Department of Urology, Austin Health, Heidelberg, Victoria, Australia.
  • Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Department of Urology, Eastern Health, Boxhill, Victoria, Australia.
  • Department of Urology, Western Health, Footscray, Victoria, Australia.
  • The University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Stewart Whalen, Jaraspong Vuthiwong, Liang G Qu

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Whalen, S., Vuthiwong, J., Qu, L. G., & Gani, J. (2025). Urodynamic Changes Following a Staged Trial of Sacral Neuromodulation in Patients With Detrusor Underactivity. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70035

Vancouver

Whalen S, Vuthiwong J, Qu LG, Gani J. Urodynamic Changes Following a Staged Trial of Sacral Neuromodulation in Patients With Detrusor Underactivity. Neurourology and Urodynamics. 2025. doi:10.1002/nau.70035

BibTeX
@article{Whalen2025,
  author = {Whalen, Stewart and Vuthiwong, Jaraspong and Qu, Liang G and Gani, Johan},
  title = {Urodynamic Changes Following a Staged Trial of Sacral Neuromodulation in Patients With Detrusor Underactivity},
  journal = {Neurourology and Urodynamics},
  year = {2025},
  doi = {10.1002/nau.70035}
}
Kostenlos starten →